Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 5 Prostatic Neoplasms, Castration-Resistant 2 Seizures 1 Prostate Cancer Metastatic 1 Primary Dysautonomias 1 Neoplasm Metastasis 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Kidney Diseases 1 Hypertension 1 Dementia 1 Cognitive Dysfunction 1

Interventions

perampanel 1 enzalutamide 1 Vigabatrin 1 Levetiracetam 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Seizures × enzalutamide × Clear all

NCT01977651 2024-12-06

UPWARD

Astellas Pharma Inc

Phase 4 Completed

424 enrolled 10 charts

Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡